Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Clinical trial NCT05856331 · COMPLETED

Trial details

NCT number: NCT05856331
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency Emphysema

Start date: 2023-10-12
Primary completion: 2025-08-06
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.